Presentations

European Medicines Verification System: long way travelled, still a long way to go….

François Bouvy, Executive Director Economic & Social Affairs, European Federation of Pharmaceutical Industries and Associations (EFPIA)

Presentation at EIPG-MGYT Joint Symposium “Crossing the bridge: A current overview of the Falsified Medicines Directive”, Budapest 2019.

The Hungarian Medicines Verification System

Dr Zsuzsanna Illés, Director, Hungarian Pharmaceutical Manufacturers’ Association

Presentation at EIPG-MGYT Joint Symposium “Crossing the bridge: A current overview of the Falsified Medicines Directive”, Budapest 2019.

EIPG Guidance on Safety Features Implementation and Qualified Persons Responsibilities

Dr Piero Iamartino, EIPG Vice-President and Scientific Association of the Pharmaceutical Industry (AFI), Italy

Presentation at EIPG-MGYT Joint Symposium “Crossing the bridge: A current overview of the Falsified Medicines Directive”, Budapest 2019.

Miklós Spaczér, Head of Department, Egis Pharmaceuticals Plc., IT Directorate, IT Development Department

Presentation at EIPG-MGYT Joint Symposium “Crossing the bridge: A current overview of the Falsified Medicines Directive”, Budapest 2019.

The impact of FMD on Healthcare Logistics and Healthcare Supply Chains

Astrid Thorissen, Dutch Industrial Pharmacists Association (NIA), Netherlands

Presentation at EIPG-MGYT Joint Symposium “Crossing the bridge: A current overview of the Falsified Medicines Directive”, Budapest 2019.

Update and status of the Falsified Medicines Directive

Claude Farrugia, EIPG President

EIPG Presentation at VAPI-UPIP Seminar “New and Emerging Regulations”, Brussels 2018.

A paradigm shift in clinical trials

Claude Farrugia, EIPG President

EIPG Presentation at European Clinical Trial Day, an international conference organised by AFI and Regione Lombardia, endorsed by EIPG, Milan 2017.

Introduzione al tema serializzazione e tracciabilità

Claude Farrugia, EIPG President

EIPG Presentation at 57 Simposio AFI, Rimini 2017.

Making the case for personalised medicine

Barbara Freischem

Presentation at EIPG – Scientific Symposium “Precision Medicine: Paradigm Shifts for Millennial Patients”, Malta 2017.

Precision medicines – delivering to patients

Tricia Kennerley

Presentation at EIPG – Scientific Symposium “Precision Medicine: Paradigm Shifts for Millennial Patients”, Malta 2017.

Shortages of medicines originating from manufacturing

Maurizio Battistini, EIPG Vice-President

EIPG Presentation at Pharmaceutical Supply Chains I, a training school organised by Cost Action CA15105: European Medicines Shortages Research Network – addressing supply problems to patients (Medicines Shortages), Lisbon 2017.

Verification of medicinal products in Europe: An EIPG perspective

Claude Farrugia, EIPG Vice-President

EIPG Presentation at VAPI-UPIP Seminar “Implementation of the new Delegated Act on Falsified Medicines”, Limelette 2016.

Formulation of protein based drugs

Claude Farrugia, EIPG Vice-President

EIPG Presentation at the EPSA Autumn Assembly 2015, Malta 2015.

Future supply chains for the pharmaceutical industry – a collaborative approach

Prof Clive Badman OBE

Presentation at EIPG – Royal Pharmaceutical Society Scientific Symposium “Advances in Technology Impacting the Pharmaceutical Industry” at the University of Strathclyde, Glasgow 2015.

CMAC: A national research centre in continuous manufacturing and crystallisation

Prof Alastair Florence

Presentation at EIPG – Royal Pharmaceutical Society Scientific Symposium “Advances in Technology Impacting the Pharmaceutical Industry” at the University of Strathclyde, Glasgow 2015.

New Medicine Evaluation, Scottish Medicines Consortium

Prof Angela Timoney

Presentation at EIPG – Royal Pharmaceutical Society Scientific Symposium “Advances in Technology Impacting the Pharmaceutical Industry” at the University of Strathclyde, Glasgow 2015.

PHAR-IN: Competences for industrial pharmacy practice in biotechnology

Prof Kristien De Paepe

Presentation at EIPG – Royal Pharmaceutical Society Scientific Symposium “Advances in Technology Impacting the Pharmaceutical Industry” at the University of Strathclyde, Glasgow 2015.

Cancer Research UK Formulation Unit

Dr Gavin Halbert

Presentation at EIPG – Royal Pharmaceutical Society Scientific Symposium “Advances in Technology Impacting the Pharmaceutical Industry” at the University of Strathclyde, Glasgow 2015.

A view on drug shortages from EIPG

Claude Farrugia, EIPG Vice-President

EIPG Presentation at VAPI-UPIP Seminar “The Challenge of Drug Shortages”, Brussels 2015.

Development of biopharmaceuticals: structure and formulation considerations

Amon Wafelman, EIPG SIG Production co-chair

EIPG Presentation at the EPSA Autumn Assembly 2014, Hradec Králové 2014.

Pharma 2014: Rework, Renaissance or Ragnarök?

Claude Farrugia, EIPG Vice-President

EIPG Lecture at meeting of Suomen Farmasialiitto, Helsinki 2014.

Industrial Pharmacist Vision of Clinical Trials

Jean Pierre Paccioni, EIPG President

Presentation at EIPG – BIPA Symposium “Clinical Trials Research” at the Faculty of Pharmacy, Medical University of Sofia, Sofia 2014.

Implementation of Annex 13 of the EU GMP Guide

Jacques Morénas, Deputy Director, Inspection Division, ANSM

Presentation at EIPG – BIPA Symposium “Clinical Trials Research” at the Faculty of Pharmacy, Medical University of Sofia, Sofia 2014.

Current Landscape for Safety Reporting in Clinical Trials

Borislav Borissov, Former Head of BDA

Presentation at EIPG – BIPA Symposium “Clinical Trials Research” at the Faculty of Pharmacy, Medical University of Sofia, Sofia 2014.

Regulatory Control of Clinical Trials

Georgina Gal, Regulatory Affairs Manager, AbbVie, Hungary

Presentation at EIPG – BIPA Symposium “Clinical Trials Research” at the Faculty of Pharmacy, Medical University of Sofia, Sofia 2014.

Biotech and Advanced Therapies: A Pharma Renaissance

Claude Farrugia, EIPG Vice-President

Presentation at EIPG – VAPI-UPIP Symposium “Biotech and Advanced Therapies: Challenges and Opportunities” at the Faculty of Medicine and Pharmacy, Campus Jette, Vrije Universiteit van Brussel, Brussels 2013.

Regulatory Perspectives on Biosimilars in Europe

Bruno Flamion, Professor of Physiology and Pharmacology, Molecular Physiology Research Unit, University of Namur

What Medical Biotechnology can Accomplish…

Luc Kupers, Director Science and Communication, Genzyme

Nanobodies®: Journey from Research to Commercial

Hilde Revets, Senior Research Fellow, Ablynx

Pharma-Economical Situation in Belgium

Leo Neels, CEO pharma.be

Biopharmaceuticals

Amon Wafelman, EIPG Netherlands Delegate

Presentation at EIPG General Assembly, Brussels 2013.

The Pharmaceutical Industry and the Industrial Pharmacist: A Partnership for the 21st Century

Claude Farrugia, EIPG Vice-President

EIPG Lecture at the meeting of the Regional Pharmacy Union of Sofia, Sofia 2012.

Introducing Inter-Professional Education into the Undergraduate Pharmacy Syllabus

Jane Nicholson, EIPG Executive Director

Presentation at EAFP Annual Conference 2012, Utrecht University, Utrecht 2012.

The Current State of the Pharmaceutical Industry in Portugal

Heitor Costa, APIFARMA Executive Director

Presentation at EIPG General Assembly, Lisbon 2012.

The implications of implementing the Directive on Falsified Medicines

Claude Farrugia, EIPG Vice-President

Presentation at Symposium at the Faculdade de Farmácia, Universidade de Lisboa, Lisbon 2012.

French pharmaceutical record (DP) and batch recall services

Jean-Pierre Paccioni, EIPG Treasurer

Presentation at Symposium at the Faculdade de Farmácia, Universidade de Lisboa, Lisbon 2012.

Pharmaceutical Industry – The challenges and the opportunities

Gino Martini, EIPG President

Presentation at Symposium at the Faculdade de Farmácia, Universidade de Lisboa, Lisbon 2012.

Challenges of Cold Supply Chain

Armin Hoffman, EIPG German Delegate

Presentation at Symposium at the Faculty of Pharmacy, University of Alcala, Madrid 2011.

Continuing Professional Development (CPD)

José C. Montilla Canís, Presidente de la Comisión Nacional de Farmacia Industrial y Galénica

Presentation at Symposium at the Faculty of Pharmacy, University of Alcala, Madrid 2011.

The Future of the Pharmaceutical Industry in Spain

Vicente Hernández Vázquez

Presentation at Symposium at the Faculty of Pharmacy, University of Alcala, Madrid 2011.

The Pharmacy Profession in the Industrial Environment: Curricula Design

Julio Alvarez-Builla, Dean of the Faculty of Pharmacy, University of Alcala

Presentation at Symposium at the Faculty of Pharmacy, University of Alcala, Madrid 2011.

Challenges and Opportunities for the Pharmaceutical Industry

Gino Martini, EIPG President

Presentation at Symposium at the Faculty of Pharmacy, University of Alcala, Madrid 2011.

Pre-Registration Pharmacist Information Pack

Sponsored by Gino Martini, EIPG President, and David Tainsh, GlaxoSmithKline Pharmaceuticals

A brochure by AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline Pharmaceuticals and MSD on pre-registration pharmacist training (Version 3.2).

Development Challenges Facing Big Pharma And The Industrial Pharmacist

Gino Martini, EIPG President

Presentation at Malta Qualified Persons Association-European Industrial Pharmacists Group-University of Malta joint seminar “The Successes And Challenges Of Today’s Pharmaceutical Industry”, Malta 2008.